Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa.
about
Inherited epidermolysis bullosaProgress toward Treatment and Cure of Epidermolysis Bullosa: Summary of the DEBRA International Research Symposium EB2015Molecular therapeutics for heritable skin diseasesAdvances in understanding and treating dystrophic epidermolysis bullosaOne goal, different strategies--molecular and cellular approaches for the treatment of inherited skin fragility disordersLysyl Hydroxylase 3 Localizes to Epidermal Basement Membrane and Is Reduced in Patients with Recessive Dystrophic Epidermolysis BullosaAminoglycosides restore full-length type VII collagen by overcoming premature termination codons: therapeutic implications for dystrophic epidermolysis bullosa.Cell therapy in dermatology.Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrityBone marrow transplantation for recessive dystrophic epidermolysis bullosaThe potential investment impact of improved access to accelerated approval on the development of treatments for low prevalence rare diseasesA single epidermal stem cell strategy for safe ex vivo gene therapy.Preconditioning of mesenchymal stem cells for improved transplantation efficacy in recessive dystrophic epidermolysis bullosaGene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa.Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEB.Animal models of skin disease for drug discovery.From marrow to matrix: novel gene and cell therapies for epidermolysis bullosa.Inherited epidermolysis bullosa: clinical and therapeutic aspects.Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: repair of the extracellular matrix.Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model.The long and winding road that leads to a cure for epidermolysis bullosa.Gene therapy: pursuing restoration of dermal adhesion in recessive dystrophic epidermolysis bullosa.A skin-depth analysis of integrins: role of the integrin network in health and disease.Inherited blistering skin diseases: underlying molecular mechanisms and emerging therapies.De novo anti-type VII collagen antibodies in patients with recessive dystrophic epidermolysis bullosa.Therapies for inherited skin fragility disorders.Recessive dystrophic epidermolysis bullosa: a review of disease pathogenesis and update on future therapies.Analysis of the functional consequences of targeted exon deletion in COL7A1 reveals prospects for dystrophic epidermolysis bullosa therapy.Junctional epidermolysis bullosa incidence and survival: 5-year experience of the Dystrophic Epidermolysis Bullosa Research Association of America (DebRA) nurse educator, 2007 to 2011.Can type VII collagen injections cure dystrophic epidermolysis bullosa?Ventricular dysfunction and aortic dilation in patients with recessive dystrophic epidermolysis bullosa.A knot polymer mediated non-viral gene transfection for skin cells.Topical application of recombinant type VII collagen incorporates into the dermal-epidermal junction and promotes wound closure.Intravenously injected recombinant human type VII collagen homes to skin wounds and restores skin integrity of dystrophic epidermolysis bullosaLong-term type VII collagen restoration to human epidermolysis bullosa skin tissue.Bone marrow cells can manipulate healing.Design and Characterization of a Human Monoclonal Antibody that Modulates Mutant Connexin 26 Hemichannels Implicated in Deafness and Skin DisordersGentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patientsHigh levels of type VII collagen expression in recessive dystrophic epidermolysis bullosa cutaneous squamous cell carcinoma keratinocytes increases PI3K and MAPK signalling, cell migration and invasion.Early intra-amniotic gene transfer using lentiviral vector improves skin blistering phenotype in a murine model of Herlitz junctional epidermolysis bullosa.
P2860
Q21202884-DBCCF4CE-0B37-4AB1-8C57-D93684EDAC1AQ26775276-11552E04-1806-4800-B1A1-4C77AA4511D0Q26865551-1D070552-F025-43FF-806D-B716D31EA743Q27006669-9818CD0A-CC40-49AC-A22C-A2AB1CE87825Q27026711-564EF306-52F1-4500-80A2-8507C150866DQ27318540-623145BD-9483-4D28-A92A-4C2E5A40D2AFQ30650123-5C6DF81A-6329-413F-9D33-739D3D15FCB3Q33653689-3DDF284A-D08B-477B-B0F5-0043E2497718Q33713926-8429B98A-766F-4772-8D38-C812455B5DC0Q34256616-2164BD3F-1830-4522-A7AD-86B3DD83FDD5Q35145713-F83090E5-BC1D-4E3B-8984-4C92516633E4Q35483739-AEF5A3FD-47C8-4BEE-BA57-85BD11BE67F2Q35655462-8D1973B8-12A5-4C62-A6AC-12BFCD202BC6Q36326838-2C383C56-5405-47B2-AFC1-9CCA421F65EBQ36595683-B748A527-C297-452C-B5DA-B9A78AD40505Q36631641-70CB4760-1CCE-438F-A387-08D678978742Q36756725-D5A7CB95-140C-4DB9-9219-291D94E6B10EQ37114261-654080B5-55A2-45A0-B036-130A0FED7553Q37649276-A4BB3459-0F02-4BA1-A5AC-DC4A137C73F2Q37658980-822429F6-600F-4C6A-820B-2D05CD56903CQ38119245-695DDD67-66C3-496C-B1F4-E9D75B91EC74Q38150897-C77A33D2-A561-4F62-8A33-6EB021986F5AQ38160890-BDA4FACE-3430-4DBC-B64A-A5A8B20F054FQ38180485-FFB0E624-3879-4CAC-B9A8-3F0EEDCEE7BAQ38379970-6FB94E45-DCD8-445D-8A17-904E3AE7EBAEQ38444460-4BF81346-C4CC-4FA6-BFDF-4FC79A7A6382Q38510204-B7D004A4-A506-4527-AFA0-6DE3C13B8577Q38772377-23D12418-858E-49B4-B1C7-7508EA9AFB43Q39410424-DB8700A5-28E3-4451-A93D-7D446C909F0DQ39500950-29BB5E33-2AF8-440E-9149-82A4172F9688Q41359672-FB2D3FA0-F8F8-4E6A-A66E-B31A1ACC6D08Q41361651-12321E7B-C227-4882-B610-A1FB85D1BA0CQ41815771-FE4CB682-1785-4BE1-B929-81EE570C6FE7Q41868932-C849839F-F466-4A5F-B304-0F6DF07799CBQ41956259-8A57B7E9-8930-4DBB-A2A6-93C826AA3CB0Q41958091-56BDED04-406B-4E45-B820-24B19A208975Q42172814-F34CAC21-0089-4717-8E7A-EE48372480E2Q42644106-652E472E-1D56-4BBE-AD8A-FF798E1DB275Q43570408-05B0ECF6-80E8-4BE6-A97E-02FB0C38B269Q45873464-48086782-5E22-44BB-A01D-D4857694AE11
P2860
Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Injection of recombinant human ...... trophic epidermolysis bullosa.
@ast
Injection of recombinant human ...... trophic epidermolysis bullosa.
@en
type
label
Injection of recombinant human ...... trophic epidermolysis bullosa.
@ast
Injection of recombinant human ...... trophic epidermolysis bullosa.
@en
prefLabel
Injection of recombinant human ...... trophic epidermolysis bullosa.
@ast
Injection of recombinant human ...... trophic epidermolysis bullosa.
@en
P2093
P2860
P356
P1433
P1476
Injection of recombinant human ...... trophic epidermolysis bullosa.
@en
P2093
David T Woodley
Douglas R Keene
Jennifer Remington
Julie Burnett
Trevor Muirhead
Xinyi Wang
Yingpin Hou
P2860
P356
10.1038/MT.2008.234
P50
P577
2008-11-18T00:00:00Z